Guangdong Raynovent Biotech Co., Ltd.

Guangdong Raynovent Biotech Co., Ltd. (referred to as 'Raynovent') is a Sino-foreign joint venture focusing on innovative drug R&D and commercialization in respiratory and metabolic diseases. It was established in October 2018, with its headquarters in Huangpu District, Guangzhou, China. It is a controlling subsidiary of Guangdong Zhongsheng Pharmaceutical Co., Ltd., a well-known A-share listed company. Raynovent focuses on developing novel therapies for major diseases and public health issues such as influenza, COVID-19, avian influenza, idiopathic pulmonary fibrosis, non-alcoholic steatohepatitis, type 2 diabetes, and weight management.

Guangdong Raynovent Biotech Co., Ltd. was established in October 2018, with its headquarters in Huangpu District, Guangzhou, China. It is a Sino-foreign joint venture focusing on innovative drug R&D and commercialization in respiratory and metabolic diseases. It is a controlling subsidiary of Guangdong Zhongsheng Pharmaceutical Co., Ltd., a well-known A-share listed company.

1. 1广东众生睿创生物科技有限公司-众生睿创raynovent.com
2. 2关于众生睿创-众生睿创raynovent.com